RochePitzer

Frank Pitzer made chief executive at NimbleGen

pharmafile | April 7, 2010 | Appointment | Research and Development NimbleGen, Roche, appointment, research and development 

Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen.

Dr Pitzer has been with Roche for eight years, and the company said he would have instrumental role in guiding NimbleGen, a global leader in microarray tools for genetic discovery and analysis, through its next stage of growth.

He was most recently head of divisional quality and regulatory affairs at Roche Diagnostics and an active member of the Diagnostics Executive Committee.

Advertisement

“We are extremely excited to announce Dr Frank Pitzer as the chief executive of Roche NimbleGen and look forward to expanding the company’s position as a leading genomics solution provider,” said Manfred Baier, head of Roche Applied Science.

“Frank’s leadership skills and extensive experience in the life science industry make him the perfect fit to guide Roche NimbleGen through the next stages of growth. His valuable insight and outstanding management experience will further entrench the company as a leading manufacturer of microarray technologies.”

Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

alzheimers_brain

Roche receives CE Mark for blood test to help rule out Alzheimer’s

Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in …

blood_test

Roche candidate shows early promise for treating haemophilia A

Roche has announced encouraging early results from its phase 1/2 trial of NXT007, an investigational …

The Gateway to Local Adoption Series

Latest content